Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
   
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  SWAN Knowledge Base
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Pathways
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Research Brief: Lucky Seven—Htt N-Terminal Structure Solved
18 September 2009. Like preschool teachers trying to arrange squirmy youngsters into a straight line, structural biologists spend days, even years, taming the unruly—in their case, coaxing fickle proteins to form crystals that reveal insight into three-dimensional structure. Through crystallography studies that experts describe as “heroic,” Mee Whi Kim and colleagues at the University of Texas Southwestern Medical Center, Dallas, have solved the secondary structure of huntingtin, the protein at the root of Huntington disease. In this month’s issue of Structure, the scientists report that huntingtin adopts a surprising variety of conformations in its N-terminal polyglutamine region, which is mutated in HD. This structural flexibility may not only explain why it has been so hard to crystallize the huntingtin protein, but also raises questions about the function of the polyglutamine stretch and how certain conformations may underlie toxicity. For their part, tau and alpha-synuclein, two other proteins blamed for driving neurodegenerative disease, are still resisting crystallographers’ efforts to visualize their 3D structure.

Scientists have toiled well over a decade trying to determine the structure of huntingtin, one of nine polyglutamine (polyQ)-containing proteins known to cause neurodegenerative disease when misfolded forms of the molecule aggregate in the brain. The current study unveils the first crystal structure of a polyQ-expanded protein (>Q10) in its native context. Seven was the magic number in this technological tour de force. “Because the structure itself is not well formed, it was very difficult to make the crystals, and the x-ray diffraction was very complicated,” Kim told ARF. “That’s why it took seven years—five to make the crystals, two to solve the structure.” Analyzing diffraction from 30 crystals, the researchers obtained structures for seven—each with the polyglutamine region in a different conformation.

The trick to getting huntingtin to crystallize was recognizing that despite the unpredictability of the polyglutamine stretch, the structures of the flanking N-terminal and polyproline regions remain fairly stable. Kim and colleagues did not crystallize the entire huntingtin protein. Rather, they expressed the first exon of 17-polyQ huntingtin in bacteria, using maltose binding protein as an N-terminal tag and a 19-amino acid tag at the C-terminal end. “Between these two contacts, I could capture my protein and get it to stabilize,” Kim said.

Consistent with predictions from prior studies, the region immediately upstream of the multi-conformational polyQ sequence invariably appeared as an alpha-helix, while the downstream region formed a classic proline helix in straight or kinked configuration (see PP1 and PP2 in image below).


Structure of Htt17Q-EX1 trimer
Htt17Q-EX1 molecules (A, B, C) consist of a-helices and PP1 or PP2 (alternative conformations), connected by a random coil region. Htt17Q-EX1 begins with the amino-terminal a-helix from Met 371 to Phe387 (green). The following poly17Q region (orange) is shown as a-helix and a loop. PP1 and PP2 contain extended polyQ loop (orange), poly11P (Blue) and polyP/Q (purple) regions. The orange cartoon with black stripe is the random coil region of polyQ. Image courtesy of Mee Whi Kim.

In an accompanying commentary, Paul Muchowski of the University of California, San Francisco, speculates on possible functional roles for the conformational flexibility of huntingtin’s polyQ region. About half of the 66 human proteins that contain at least five glutamine repeats demonstrate considerable length polymorphism in the polyQ stretch. To Muchowski, this suggests that the ability to assume a variety of conformations might be essential for normal proteins that need to function within a wide range of polyQ lengths. He also notes that polyQ proteins are overrepresented in transcription-related processes, raising the possibility that conformational flexibility is important for these activities.

Another looming question is the N-terminal structure of pathological (Q36 or greater) huntingtin protein. The current study examined 17-polyQ huntingtin, which falls within the range of polyQ lengths in the normal population. “We still don't know the toxic conformation,” Kim said. “We have to work on proteins with longer glutamine stretches to see the conformation change there.” Based on the published data, she and colleagues propose that huntingtin’s pathogenic polyQ expansion “increases the length of the random coil, which promotes aggregation and facilitates abnormal interactions with other proteins in cells.”

Researchers are beginning to study polyQ stretches and other short tandem repeats on a whole-genome basis, as reported in a separate study published in this week’s PNAS Early Edition. Michael Molla of Boston University, Massachusetts, and colleagues catalogued all triplet repeats and their flanking regions. These authors propose that such data can be used to eventually design a cost-effective whole-genome assay to determine disease risk or to guide personalized genomic strategies relevant to drug response.—Esther Landhuis

References
Kim MW, Chelliah Y, Kim SW, Otwinowski Z, Bezprozvanny I. Secondary Structure of Huntingtin Amino-Terminal Region. Structure. 2009 Sept 9;17:1205-1212. Abstract

Miller J, Rutenber E, Muchowski PJ. Polyglutamine Dances the Conformational Cha-Cha-Cha. Structure. 2009 Sept 9;17:1151-1153. Abstract

Molla M, Delcher A, Sunyaev S, Cantor C, Kasif S. Triplet repeat length bias and variation in the human transcriptome. PNAS Early Edition. Sept 2009. No abstract available. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2010 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad